Defining “optimal recovery” in colorectal surgery: a path to precision prehabilitation Authors: Chun Gao, Li Zhu, Cheng Cheng Jin, Sheng Zhang Published: 2026 ABSTRACT AbstractPurpose This study defined “optimal recovery” as a multidimensional composite endpoint for colorectal cancer surgery and investigated whether its predictors were specific to tumor location.Methods In this retrospective cohort of 396 patients undergoing curative-intent resection, optimal recovery required achievement of 5 criteria: no major complications, timely gastrointestinal recovery, ambulation by postoperative day (POD) 2, oral intake by POD 4, and discharge by POD 7. Multivariable logistic regression was used to identify predictors in the overall cohort and site-specific subgroups. The endpoint was then evaluated against 30-day patient-reported outcomes using the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30).Results The optimal recovery rate was 44.4%. Four independent predictors emerged: age <60 years (odds ratio [OR], 2.35; P<0.001), prognostic nutritional index (PNI) ≥46 (OR, 2.70; P<0.001), operation time ≤180 minutes (OR, 2.94; P<0.001), and blood loss ≤30 mL (OR, 2.17; P=0.005). Subgroup analysis revealed marked divergence between cancer sites: blood loss was the dominant predictor in colon cancer (OR, 6.67; P<0.001), whereas PNI predominated in rectal cancer (OR, 2.56; P=0.005). Patients achieving optimal recovery reported significantly better global health status (72.4 vs. 63.8; P<0.001) and physical functioning (83.5 vs. 74.2; P<0.001) at 30 days.Conclusion Optimal recovery provides a stringent quality benchmark, with findings highlighting site-specific determinants of recovery. Recovery after colon surgery was associated primarily with technical factors, particularly lower blood loss, whereas recovery after rectal surgery was strongly linked to nutritional status. These results support precision prehabilitation strategies tailored to site-specific pathophysiology.Trial registrationRegistered in the Chinese Clinical Trial Registry (No. ChiCTR2300075424) on September 9, 2023.Keywords: Postoperative care, Colorectal surgery, Nutrition assessment, Textbook outcome, Precision medicine INTRODUCTION Colorectal cancer remains a major global health challenge. Recent data from the United States project that it will account for 8% of new cancer cases in men and 7% in women in 2025, underscoring its substantial disease burden [1]. Although resection remains a cornerstone of curative treatment, achieving an optimal postoperative course with respect to short-term recovery as well as long-term survival is challenging. Both tumor biology and the patient’s physiological response to surgical stress shape recovery, making postoperative recovery quality a key endpoint [2, 3]. For decades, surgical quality has been assessed using isolated metrics, such as complication rates or length of stay (LOS). However, these single measures provide only a fragmented and sometimes misleading picture. A short hospital stay has limited value if it is followed by rapid readmission, and the absence of one complication may obscure the occurrence of another [4, 5]. Accordingly, this approach fails to capture the ideal multidimensional postoperative course and highlights the need for composite endpoints that reflect the full recovery experience [6]. The concept of “Textbook Outcome” (TO) was developed to address this need. It defines the ideal postoperative course as the simultaneous achievement of all desired outcome benchmarks, thereby converting multiple individual parameters into a single composite measure of success [7, 8]. In colorectal surgery, however, the proliferation of TO definitions has created ambiguity and hindered meaningful comparison across studies [6]. More importantly, the biological and technical differences between colon and rectal resections suggest that the determinants of optimal recovery may not be uniform across procedures. The confined pelvic anatomy of rectal surgery, along with its implications for anastomotic integrity and neural preservation, likely imposes different perioperative demands from those of intra-abdominal colon resection [9–11]. Accordingly, this study had 3 objectives. First, we sought to establish a stringent and clinically relevant definition of “optimal recovery” for colorectal cancer surgery. Second, we aimed to determine the rate at which this ideal outcome was achieved in a contemporary cohort. Third, and most notably, we examined whether the preoperative and intraoperative predictors of optimal recovery differed between patients with colon cancer and those with rectal cancer, thereby providing a rationale for biologically informed, site-specific perioperative management. METHODS Ethics statement This study was approved by the Institutional Medical Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (No. TJ-IRB202512137). The requirement for informed consent was waived due to the use of deidentified data and the retrospective nature of the study. The study was registered in the Chinese Clinical Trial Registry (No. ChiCTR2300075424) on September 9, 2023. All aspects of this study complied with the principles of the Declaration of Helsinki and were reported in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines (Supplementary Material 1) [12]. Study design and population We conducted a single-center retrospective cohort study. The study population comprised consecutive patients who underwent elective curative-intent resection for histologically confirmed colorectal adenocarcinoma between September 2020 and November 2022.s Of 558 patients initially assessed, 505 met the preliminary inclusion criteria. We then excluded patients who underwent emergency surgery (n=54), received palliative procedures (n=39), had synchronous malignancies (n=5), or had incomplete key data (n=11). The final analytic cohort included 396 patients. Fig. 1 illustrates the patient selection process. Patient selection flowchart. Data collection and variable definitions We systematically extracted data from a prospectively maintained institutional database. Collected variables included demographic and clinical characteristics, tumor characteristics, preoperative laboratory variables, and operative details. Demographic and clinical characteristics included age, sex, body mass index, and American Society of Anesthesiologists (ASA) physical status classification. Tumor characteristics included primary tumor location (colon vs. rectum) and pathological TNM stage [13, 14]. For preoperative laboratory testing, we recorded values from the assessment performed immediately before surgery, including the absolute neutrophil count, absolute lymphocyte count, absolute monocyte count, platelet count, serum albumin, total bilirubin, and estimated glomerular filtration rate. We also calculated derived indices, including the neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, lymphocyte to monocyte ratio, systemic immune-inflammation index ([platelets × neutrophils] / lymphocytes), and prognostic nutritional index (PNI = albumin [g/L] + 5 × total lymphocyte count [×109/L]). Operative details included surgical approach (laparoscopic vs. open/converted to open), operation time, intraoperative blood loss, creation of a diverting stoma, and performance of multivisceral resection. Multivisceral resection was defined as concomitant resection of 1 or more additional organs beyond the primary colorectal specimen. Indications for multivisceral resection included suspected or confirmed tumor adherence/invasion (n=4), synchronous benign pathology (cholecystectomy for gallstones, n=12; oophorectomy for ovarian cysts, n=6), and incidental findings requiring intervention. We included these patients in the primary analysis to reflect real-world surgical practice and adjusted for multivisceral resection in the multivariable models. Outcome definition of optimal recovery We defined the primary outcome, “optimal recovery,” as a composite endpoint requiring the simultaneous fulfillment of all 5 of the following criteria during the index hospitalization and within the 30-day postoperative period: (1) Absence of major postoperative complications, defined as any adverse event requiring surgical, endoscopic, or radiological intervention, corresponding to Clavien-Dindo grade III or higher [15, 16]. (2) Timely recovery of gastrointestinal function: For patients without a stoma, first passage of flatus or stool via the anus on or before postoperative day (POD) 3. For patients with a diverting stoma, stoma output within 24 hours and transition to bilious effluent within 48 hours. (3) Timely recovery of physical mobility: Independent ambulation for at least 30 cumulative minutes beginning on POD 2. (4) Timely recovery of oral intake: Tolerance of oral intake (liquid or semi-liquid diet) without the need for supplemental parenteral nutrition by POD 4. This definition was intended to capture the clinically meaningful endpoint of nutritional autonomy rather than mere initiation of oral intake. Although Enhanced Recovery After Surgery (ERAS) guidelines recommend early oral feeding within 24 hours [17], clinical experience suggests that many patients, particularly in Asian populations in which cultural factors may influence postoperative eating behaviors, require supplemental parenteral nutrition due to inadequate oral consumption despite resuming oral intake early [18]. Our definition thus focuses on the functional endpoint of nutritional independence, which may reflect gastrointestinal recovery more accurately than simple initiation of oral intake. (5) Timely hospital discharge: Postoperative LOS ≤7 days and no readmission within 30 days after discharge. Patient-reported outcome assessment We collected health-related quality-of-life data at 30 days postoperatively using the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30). The EORTC QLQ-C30 is a validated 30-item instrument comprising 5 functional scales (physical, role, emotional, cognitive, and social), 3 symptom scales (fatigue, nausea/vomiting, and pain), 6 single-item measures (dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties), and a global health status/QoL scale [19]. All scores were linearly transformed to a 0–100 scale according to the EORTC scoring manual. Higher scores on the global health status and functional scales indicate better quality of life, whereas higher scores on the symptom scales indicate greater symptom burden. We compared health-related quality-of-life scores between patients who achieved optimal recovery and those who did not using the independent-samples t-test or Mann-Whitney U-test, as appropriate. The minimal clinically important difference (MCID) for the EORTC QLQ-C30 was defined as 5–10 points, based on previously established thresholds [20]. Statistical analysis Continuous variables are presented as mean±standard deviation or median with interquartile range (IQR), depending on their distribution, and were compared using the Student t-test or Mann-Whitney U-test. Categorical variables are presented as frequencies and percentages and were compared using the chi-square test or Fisher exact test. Predictors of optimal recovery were first examined using univariate logistic regression. Variables with P<0.1 in univariate analysis were entered into a multivariable logistic regression model with backward stepwise selection (retention threshold, P<0.05). To improve clinical interpretability, we redefined the reference categories for continuous variables that were dichotomized at clinically meaningful cut points so that odds ratios (ORs) >1 would consistently indicate positive predictors of optimal recovery. Results from the final model are reported as adjusted ORs (aORs) with 95% confidence intervals (CIs). We performed a prespecified subgroup analysis by stratifying the cohort into colon cancer and rectal cancer groups. Separate multivariable models were constructed for each subgroup to identify location-specific predictors. A 2-sided P-value of less than 0.05 was considered to indicate statistical significance. All analyses were performed using IBM SPSS ver. 26.0 (IBM Corp) and R ver. 4.1.0 (R Foundation for Statistical Computing). RESULTS Patient characteristics and optimal recovery rate Our analysis included 396 patients who underwent curative-intent resection for colorectal cancer. The cohort had a mean age of 61.8±10.4 years and a balanced sex distribution, with 58.6% male patients. Tumors were located in the colon in 170 patients (42.9%) and in the rectum in 226 (57.1%) (Table 1). Overall, 176 patients (44.4%) achieved optimal recovery. Table 1.Baseline characteristics of the study population stratified by achievement of optimal recoveryCharacteristicOverall cohort (n=396)Optimal recovery group (n=176)Nonoptimal recovery group (n=220)P-valueAge (yr)61.8±10.458.4±10.064.6±9.9<0.001Male sex232 (58.6)102 (58.0)130 (59.1)0.838Body mass index (kg/m2)22.5±3.322.7±3.122.4±3.40.348ASA physical status<0.001 I–II368 (92.9)176 (100)192 (87.3) III–IV28 (7.1)0 (0)28 (12.7)Tumor location<0.001 Colon170 (42.9)56 (31.8)114 (51.8) Rectum226 (57.1)120 (68.2)106 (48.2)TNM stage0.129 I–II234 (59.1)110 (62.5)124 (56.4) III–IV162 (40.9)66 (37.5)96 (43.6)Neoadjuvant therapy26 (6.6)14 (8.0)12 (5.5)0.213Laboratory finding Neutrophil count (×109/L)3.61±1.553.56±1.353.65±1.700.572 Lymphocyte count (×109/L)1.49±0.531.54±0.561.45±0.500.121 Monocyte count (×109/L)0.48±0.200.46±0.180.49±0.210.050 Hemoglobin (g/L)118.3±22.7122.8±23.1114.8±21.8<0.001 Platelet count (×109/L)237.6±83.5236.3±76.3238.6±88.90.791Neutrophil to lymphocyte ratio2.8±2.92.9±3.92.7±1.50.566Platelet to lymphocyte ratio179.4±94.8174.5±88.7183.3±99.50.356Lymphocyte to monocyte ratio3.51±1.843.83±2.233.25±1.400.002Albumin (g/L)39.6±3.840.7±3.038.8±4.2<0.001Total bilirubin (μmol/L)10.6±4.711.3±4.410.0±4.80.010eGFR (mL/min/1.73 m2)85.8±17.388.9±17.083.4±17.20.002PNI47.1±4.948.4±4.246.1±5.2<0.001SII665.5±542.5657.2±591.7672.2±501.00.785Operation time (min)214.2±54.5202.4±54.4223.6±52.7<0.001Intraoperative blood loss (mL)62.8±30.249.5±19.373.5±35.9<0.001Operation type<0.001 Laparoscopic382 (96.5)176 (100)206 (93.6) Open14 (3.5)0 (0)14 (6.4)Stoma80 (20.2)40 (22.7)40 (18.2)0.314Multivisceral resection22 (5.6)4 (2.3)18 (8.2)0.014Values are presented as mean±standard deviation or number (%).ASA, American Society of Anesthesiologists; eGFR, estimated glomerular filtration rate; PNI, prognostic nutritional index; SII, systemic immune-inflammation index. Baseline characteristics of the study population stratified by achievement of optimal recovery Values are presented as mean±standard deviation or number (%). ASA, American Society of Anesthesiologists; eGFR, estimated glomerular filtration rate; PNI, prognostic nutritional index; SII, systemic immune-inflammation index. Stratification by optimal recovery status revealed marked baseline differences. Patients in the optimal recovery group were significantly younger than those in the nonoptimal recovery group (58.4±10.0 years vs. 64.6±9.9 years, P<0.001), and all had ASA physical status I–II (100% vs. 87.3%, P<0.001). They also exhibited better preoperative physiological status, with higher albumin levels (40.7±3.0 g/L vs. 38.8±4.2 g/L, P<0.001), PNI values (48.4±4.2 vs. 46.1±5.2, P<0.001), and lymphocyte to monocyte ratio (3.83±2.23 vs. 3.25±1.40, P=0.002). Operative characteristics also differed between groups: patients who achieved optimal recovery had shorter operation times (202.4±54.4 minutes vs. 223.6±52.7 minutes, P<0.001), lower intraoperative blood loss (49.5±19.3 mL vs. 73.5±35.9 mL, P<0.001), and a higher rate of minimally invasive surgery (100% vs. 93.6%, P<0.001). Rectal cancer was associated with a significantly higher optimal recovery rate than colon cancer (53.1% vs. 32.9%, P<0.001). The definition of the composite endpoint and the achievement rates for its individual components are presented in Table 2. The criterion for timely gastrointestinal recovery was met by 91.8% of patients without a stoma and by 82.5% of those with a stoma. Among patients who received a diverting stoma, 68.8% (55 of 80) underwent surgery for rectal cancer. Table 2.Detailed definition and achievement rate of the components constituting the “optimal recovery” composite endpoint (n=396)Component of optimal recoveryOperational definitionNo. of patients (%)(1) Absence of major complicationsNo Clavien-Dindo grade III or higher complications occurring within 30 days postoperatively, including during readmission380 (96.0)(2) Timely recovery of gastrointestinal function356 (89.9) In patients without a stoma (n=316)First passage of flatus or stool via the anus on or before POD 3290 (91.8) In patients with a diverting stoma (n=80)Stoma output within 24 hr of surgery AND transition to bilious effluent within 48 hr66 (82.5)(3) Timely recovery of physical mobilityAbility to ambulate independently for at least cumulative 30 min starting from POD 2310 (78.3)(4) Timely recovery of oral intakeTolerance of oral intake (liquid or semi-liquid diet) by POD 4, without requiring supplemental parenteral nutrition340 (85.9)(5) Timely hospital dischargePostoperative length of stay ≤7 days, and no readmission within 30 days after discharge216 (54.5)Overall optimal recovery (composite endpoint)Fulfillment of ALL 5 components listed above176 (44.4)POD, postoperative day. Detailed definition and achievement rate of the components constituting the “optimal recovery” composite endpoint (n=396) POD, postoperative day. Predictors of optimal recovery in the overall cohort Univariate analysis identified several variables associated with optimal recovery (Table 3). Multivariable logistic regression subsequently identified 4 independent predictors (Table 3, Fig. 2A). Patients aged <60 years had 2.35-fold higher odds of achieving optimal recovery (95% CI, 1.51–3.66; P<0.001). Three additional positive predictors were identified: preoperative PNI ≥46 (aOR, 2.70; 95% CI, 1.64–4.45; P<0.001), operation time ≤180 minutes (aOR, 2.94; 95% CI, 1.67–5.18; P<0.001), and intraoperative blood loss ≤30 mL (aOR, 2.17; 95% CI, 1.27–3.72; P=0.005). Table 3.Univariate and multivariable logistic regression analyses for predictors of optimal recoveryVariableUnivariate analysisMultivariable analysisaOR (95% CI)P-valueaOR (95% CI)P-valueAge (<60 yr vs. ≥60 yr)2.84 (1.89–4.27)<0.0012.35 (1.51–3.66)<0.001Sex (female vs. male)1.05 (0.70–1.58)0.838BMI (≥25 kg/m2 vs. <25 kg/m2)1.12 (0.71–1.76)0.348ASA physical status (I–II vs. III–IV)NE<0.001bLMR (≥3.35 vs. <3.35)1.54 (1.03–2.30)0.035Albumin (≥40 g/L vs. <40 g/L)2.53 (1.70–3.77)<0.001Total bilirubin (≥10 μmol/L vs. <10 μmol/L)1.64 (1.10–2.45)0.015PNI (≥46 vs. <46)3.85 (2.50–5.93)<0.0012.70 (1.64–4.45)<0.001Operation time (≤180 min vs. >180 min)3.45 (2.08–5.72)<0.0012.94 (1.67–5.18)<0.001Intraoperative blood loss (≤30 mL vs. >30 mL)3.45 (2.08–5.73)<0.0012.17 (1.27–3.72)0.005Operation type (laparoscopic vs. open)NE<0.001bMultivisceral resection (no vs. yes)3.83 (1.27–11.54)0.017OR >1 indicates a positive predictor.OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio; BMI, body mass index; ASA, American Society of Anesthesiologists; LMR, lymphocyte to monocyte ratio; PNI, prognostic nutritional index; NE, not estimable.aBackward stepwise regression analysis. ASA physical status, LMR, albumin, and total bilirubin were not retained in the final multivariable logistic regression model after backward stepwise selection using a retention threshold of P<0.05. Therefore, there are no aOR (95% CI) values to report for these variables. bFor ASA physical status and operation type, univariate ORs were NE because of zero-event cells; the corresponding P-values were obtained using the Fisher exact test. Univariate and multivariable logistic regression analyses for predictors of optimal recovery OR >1 indicates a positive predictor. OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio; BMI, body mass index; ASA, American Society of Anesthesiologists; LMR, lymphocyte to monocyte ratio; PNI, prognostic nutritional index; NE, not estimable. aBackward stepwise regression analysis. ASA physical status, LMR, albumin, and total bilirubin were not retained in the final multivariable logistic regression model after backward stepwise selection using a retention threshold of P<0.05. Therefore, there are no aOR (95% CI) values to report for these variables. bFor ASA physical status and operation type, univariate ORs were NE because of zero-event cells; the corresponding P-values were obtained using the Fisher exact test. Forest plot of multivariable analysis for predictors of optimal recovery. (A) Overall cohort (n=396). (B) Subgroup analysis of patients with colon cancer (n=170). (C) Subgroup analysis of patients with rectal cancer (n=226). Odds ratio (OR) of >1 indicates a positive predictor of optimal recovery. CI, confidence interval; PNI, prognostic nutritional index. Site-specific prediction patterns Subgroup analysis revealed distinct predictor profiles for colon and rectal cancer (Table 4, Fig. 2B, C). In the colon cancer subgroup (n=170), intraoperative blood loss ≤30 mL was the strongest predictor of optimal recovery (OR, 6.67; 95% CI, 2.50–20.0; P<0.001), followed by operation time ≤180 minutes (OR, 5.88; 95% CI, 2.00–17.33; P=0.001). PNI was not significantly associated with optimal recovery in this subgroup (P=0.102). Table 4.Multivariable analysis of predictors for optimal recovery: subgroup analysis by tumor locationVariablesColon cancer cohort (n=170)Rectal cancer cohort (n=226)OR (95% CI)P-valueOR (95% CI)P-valueAge (<60 yr vs. ≥60 yr)2.87 (1.63–5.05)<0.0012.53 (1.41–4.55)0.001PNI (≥46 vs. <46)2.00 (0.87–4.59)0.1022.56 (1.33–4.93)0.005Operation time (≤180 min vs. >180 min)5.88 (2.00–17.33)0.0012.78 (1.41–5.48)0.003Intraoperative blood loss (≤30 mL vs. >30 mL)6.67 (2.50–20.0)<0.0011.45 (0.73–2.88)0.289OR >1 indicates a positive predictor.OR, odds ratio; CI, confidence interval; PNI, prognostic nutritional index. Multivariable analysis of predictors for optimal recovery: subgroup analysis by tumor location OR >1 indicates a positive predictor. OR, odds ratio; CI, confidence interval; PNI, prognostic nutritional index. In the rectal cancer subgroup (n=226), adequate nutritional status was a significant predictor of optimal recovery (PNI ≥46: OR, 2.56; 95% CI, 1.33–4.93; P=0.005), as was operation time ≤180 minutes (OR, 2.78; 95% CI, 1.41–5.48; P=0.003). Intraoperative blood loss was not significantly associated with optimal recovery in this subgroup (P=0.289). Age remained a positive predictor in both subgroups (colon cancer: OR, 2.87; rectal cancer: OR, 2.53). Patient-reported outcomes at 30 days postoperatively Patients who achieved optimal recovery reported significantly better health-related quality-of-life scores across multiple domains at 30 days postoperatively (Supplementary Table 1). The global health status/quality-of-life score was higher in the optimal recovery group than in the nonoptimal recovery group (72.4±8.6 vs. 63.8±9.2; mean difference, 8.6; 95% CI, 6.8–10.4; P<0.001). All functional scales were higher in the optimal recovery group, with the largest differences observed for physical functioning (83.5±7.8 vs. 74.2±9.1; mean difference, 9.3; P<0.001) and role functioning (78.6±9.4 vs. 68.3±10.2; mean difference, 10.3; P<0.001). Social functioning also differed significantly between groups (75.8±8.9 vs. 67.4±9.8; mean difference, 8.4; P=0.002), whereas differences in emotional and cognitive functioning were smaller (P=0.012 and P=0.028, respectively). Regarding symptom burden, patients in the optimal recovery group reported significantly less fatigue (28.4±7.2 vs. 36.5±8.4; mean difference, −8.1; P<0.001), pain (22.6±6.8 vs. 30.2±7.9; mean difference, −7.6; P<0.001), and appetite loss (18.3±5.4 vs. 25.7±6.8; mean difference, −7.4; P<0.001). Nausea/vomiting, constipation, and diarrhea did not differ significantly between groups (P=0.182, P=0.214, and P=0.096, respectively). Scores for insomnia, dyspnea, and financial difficulties were also comparable between groups (P=0.124, P=0.208, and P=0.342, respectively). We next evaluated the discriminatory ability of 3 outcome metrics—optimal recovery, prolonged LOS (>7 days), and complication status—with respect to hospitalization costs using medians and IQRs (Fig. 3). The largest cost difference was observed for LOS. Patients discharged within 7 days had significantly lower median costs (¥67,510.74; IQR, ¥62,275.88–¥72,130.64) than those with longer hospital stays (¥79,043.78; IQR, ¥71,557.51–¥86,330.71). Optimal recovery also differentiated hospitalization costs: patients who achieved this endpoint had median costs of ¥67,471.39 (IQR, ¥61,949.67–¥71,037.05), whereas those who did not had median costs of ¥77,253.47 (IQR, ¥68,253.99–¥83,785.79), a difference of ¥9,782.08. Complication status similarly differentiated costs, with lower median costs among patients without complications (¥69,463.39; IQR, ¥63,750.61–¥78,239.86) than among those with complications (¥77,325.34; IQR, ¥69,586.67–¥85,061.06), a difference of ¥7,861.95. Box plot comparison of hospitalization costs stratified by different outcome metrics. (A) Optimal recovery status. (B) Postoperative length of stay (LOS). (C) Complication status. DISCUSSION This study establishes optimal recovery as a stringent multidimensional endpoint for colorectal surgery, achieved by 44.4% of patients in our cohort. Notably, the predictors of this endpoint differed by tumor location. Intraoperative blood loss was the strongest predictor in colon cancer, whereas PNI was the strongest predictor in rectal cancer. These findings suggest that the determinants of postoperative recovery may vary according to surgical site and challenge a one-size-fits-all approach to perioperative care and risk stratification [2, 21]. The principal strength of the optimal recovery endpoint lies in its integrative nature, which addresses the limitations of single-metric assessments [22, 23]. Although most patients avoided a major complication (96%) and 85.9% achieved timely oral intake, only 44.4% met all 5 criteria simultaneously. This discrepancy suggests that conventional metrics may overestimate the proportion of patients who experience a truly seamless postoperative course. By requiring the concurrent achievement of multiple interdependent recovery milestones, optimal recovery provides a more rigorous and clinically meaningful benchmark of surgical quality [3]. The choice of POD 4 as the threshold for nutritional autonomy warrants explanation. This cutoff is broadly consistent with the expected physiological course of gastrointestinal recovery, as postoperative ileus typically resolves within 48 to 72 hours [24]. More importantly, our definition required tolerance of oral intake without parenteral nutritional support, thereby distinguishing nutritional independence from simple initiation of oral feeding. In routine clinical practice, particularly in Chinese healthcare settings, patients may resume oral intake early but consume insufficient amounts because of cultural factors, postoperative fatigue, or anxiety, thus requiring supplemental parenteral nutrition [18]. By emphasizing nutritional independence rather than feeding initiation, this criterion may better capture meaningful functional recovery. The achievement rate for this component (85.9%) further supports its clinical feasibility (Table 2). The identification of age and operative duration as predictors across the overall cohort is biologically plausible, as physiological reserve generally declines with age and prolonged surgery can directly amplify the systemic stress response [24]. The finding that preoperative nutritional status was a significant predictor for rectal cancer provides additional nuance. This result is consistent with previous studies linking malnutrition to anastomotic leakage and impaired immune competence, which may be particularly relevant in the confined technical setting of pelvic surgery [25, 26]. Our study differs intentionally from the prevailing TO construct, many versions of which incorporate long-term oncological measures such as resection margin status and lymph node yield [5, 21, 27, 28]. Although TO metrics are valuable for assessing overall cancer care quality, they do not necessarily capture the granularity of early postoperative recovery. By focusing exclusively on immediate physiological recovery, the optimal recovery endpoint is intended to provide a more specific measure of short-term surgical convalescence. The association between optimal recovery and patient-reported outcomes supports the clinical relevance of this endpoint. Patients who achieved optimal recovery had better health-related quality-of-life scores at 30 days postoperatively, with differences exceeding established MCID thresholds for global health status, physical functioning, and role functioning [20]. This concordance between clinician-defined recovery criteria and patient-perceived recovery addresses a key gap in surgical quality assessment [29]. The EORTC QLQ-C30 findings further suggest that patients who achieved optimal recovery experienced better functional recovery and lower symptom burden after discharge. Notably, the absence of significant between-group differences in certain gastrointestinal symptoms, including nausea, constipation, and diarrhea, may indicate that some aspects of postoperative bowel dysfunction persist regardless of overall recovery status [30]. The finding that patients with rectal cancer had higher optimal recovery rates despite undergoing more technically demanding procedures requires careful interpretation. Although initially counterintuitive, this result highlights a core consideration in composite endpoint design: definitions of recovery must account for procedure-specific differences in the postoperative course [2]. In our cohort, this pattern appeared to result primarily from the different criteria used to define gastrointestinal recovery in patients with and without a stoma, together with the high proportion of patients with rectal cancer who received diverting stomas. For patients with a stoma, timely gastrointestinal recovery was defined by early stoma function (output within 24 hours and bilious effluent within 48 hours), which represents a different physiological threshold from spontaneous passage of flatus or stool via the anus [9]. Although this distinction is clinically appropriate, it may create an apparent advantage for the stoma subgroup. Importantly, however, this observation does not undermine the validity of our site-specific predictor analysis, which showed that the factors associated with optimal recovery differed by tumor location. In rectal cancer, despite the higher overall optimal recovery rate, nutritional status (PNI) remained the dominant predictor, consistent with the greater metabolic demands of pelvic dissection and anastomotic healing [31–33]. The marked divergence in predictors between the colon and rectal surgery cohorts points to meaningful differences in the biology of recovery. In colon surgery, the strong association between blood loss and optimal recovery is consistent with the role of operative blood loss in the systemic inflammatory response. Even relatively limited hemorrhage may trigger proinflammatory cytokines, such as interleukin 6 and tumor necrosis factor α, as well as stress hormone release, which can impair gastrointestinal motility and delay functional recovery [34, 35]. This pattern may help explain why technical precision is especially important in abdominal procedures, where anastomotic healing occurs in a comparatively less constrained anatomical environment. In contrast, the prominence of nutritional status in rectal cancer likely reflects the vulnerabilities of pelvic surgery. The narrow confines of the pelvis require meticulous dissection near critical neural structures, creating a setting in which microvascular compromise and tissue oxygenation can govern healing [31]. Malnutrition, through hypoalbuminemia and lymphocytopenia, can contribute to impaired tissue repair and immune defense, thereby increasing vulnerability to anastomotic leakage and septic complications [32, 33]. The modifiability of the identified predictors warrants consideration. Although age is not modifiable, its identification remains important for risk stratification, enabling targeted allocation of prehabilitation resources to older patients who may derive the greatest benefit [36]. More crucially, our site-specific analysis suggests different interventional priorities according to tumor location: in colon cancer, the prominence of blood loss as a predictor directs attention toward technical optimization, whereas in rectal cancer, nutritional status emerges as a clearly modifiable preoperative target. This distinction has direct clinical implications. For patients scheduled for rectal resection, our findings support systematic nutritional screening using PNI and the implementation of preoperative nutritional support when indicated, both of which have established efficacy [25, 37]. For patients undergoing colon resection, although blood loss itself cannot be modified preoperatively, its identification as a key predictor reinforces the importance of optimizing surgical technique and using minimally invasive approaches when feasible [38]. Thus, rather than limiting clinical applicability, our results provide a biologically informed framework for resource allocation: nutritional intervention for rectal cancer and technical optimization for colon cancer. This precision-oriented approach to prehabilitation may represent a meaningful advance beyond generic one-size-fits-all protocols [39]. Clinical implications and limitations Our cost analysis showed that all 3 metrics—optimal recovery, LOS, and complication status— were associated with differences in hospitalization costs, although the largest difference was observed for LOS, underscoring that healthcare economics remain dominated by temporal factors. The relatively low optimal recovery rate (44.4%), driven primarily by failure to meet the LOS ≤7 days criterion (achieved by only 54.5% of patients), likely reflects healthcare-system and cultural factors. In Chinese healthcare settings, postoperative hospitalization often remains longer than in Western settings because of family expectations favoring inpatient recovery, relatively low daily hospitalization costs, and the absence of bundled payment systems that incentivize earlier discharge [40]. These contextual factors may explain why the median LOS in our cohort (8 days) exceeded that reported in many Western ERAS series [41], while still remaining appropriate within the local healthcare environment. In this context, the value of optimal recovery may lie less in identifying short hospital stays alone and more in identifying patients who recover efficiently and with high overall postoperative quality. Several limitations should be acknowledged. First, the retrospective single-center design introduces the possibility of selection bias and residual confounding. Although the sample size was adequate for the primary analysis, it did not permit robust internal validation of the prediction model through data splitting, making external validation necessary. Second, although patient-reported outcomes were collected prospectively at 30 days (Supplementary Table 1), follow-up remained limited to the index hospitalization and the early postoperative period. As a result, readmissions to outside institutions, late complications, and longer-term functional recovery beyond 30 days could not be assessed [30]. Third, the composite endpoint assigns equal weight to all 5 components, although their clinical importance may differ. Finally, potential socioeconomic confounders that may influence postoperative recovery were not included in the analysis. We retained patients who underwent multivisceral resection (n=22, 5.6%) in the primary analysis because the additional procedural complexity varied substantially. Specifically, 12 patients underwent cholecystectomy for incidental gallstones, 6 underwent oophorectomy for benign ovarian cysts, and only 4 required resection of adjacent organ invasion. Thus, in most cases, the additional procedures likely added limited complexity beyond the primary colorectal resection. Multivisceral resection status was included in the multivariable models and was not independently associated with optimal recovery (P=0.121), suggesting that any effect may have been mediated through other operative variables, such as operation time. Prospective multicenter studies will be needed to further validate optimal recovery. Such studies should incorporate systematic collection of patient-reported outcomes at 30 and 90 days, rigorous capture of 90-day readmissions regardless of treatment facility, external validation of the site-specific prediction models, and assessment of the relationship between optimal recovery and long-term oncological outcomes. It may also be valuable to determine whether optimal recovery predicts sustained functional recovery and freedom from readmission more effectively than LOS alone. Conclusions For the first time, we established “optimal recovery” as a rigorous, multidimensional endpoint that identifies the ideal postoperative pathway in colorectal cancer surgery. We demonstrated that the determinants of surgical recovery differ according to tumor location. The finding that intraoperative blood loss was the key predictor in colon cancer, whereas nutritional status was the key predictor in rectal cancer, provides a biologically informed framework for precision prehabilitation. These site-specific predictors support targeted interventions, technical precision for colon procedures and metabolic optimization for rectal surgery, that address the distinct pathophysiological demands of each anatomical site. Validation against patient-reported outcomes further suggests that optimal recovery captures clinically meaningful differences in quality of life, supporting its use as a patient-centered benchmark. Future prospective studies incorporating patient-reported outcomes and long-term follow-up will be important to further validate optimal recovery as a benchmark of surgical quality and to clarify its role in guiding resource allocation to improve both clinical outcomes and healthcare value. Footnotes Conflict of interest No potential conflict of interest relevant to this article was reported. Funding This study was supported by the 2024 Wu Jieping Medical Foundation - CSPEN Clinical Nutrition Research Project (No. 320.6750.2024-25-17). Author contributions Conceptualization: all authors; Data curation: CCJ; Formal analysis: LZ; Methodology: CCJ; Project administration: LZ; Software: CCJ; Writing–original draft: SZ, CG; Writing–review & editing: all authors. All authors read and approved the final manuscript. Supplementary materials Supplementary Material 1. STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist. Supplementary Table 1. Comparison of health-related quality-of-life scores (EORTC QLQ-C30) at 30 days postoperatively, stratified by optimal recovery status Supplementary materials are available from https://doi.org/10.3393/ac.2026.00080.0011. REFERENCES Associated Data Supplementary Materials Supplementary Material 1. STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist. Supplementary Table 1. Comparison of health-related quality-of-life scores (EORTC QLQ-C30) at 30 days postoperatively, stratified by optimal recovery status